Carlyle Secured Lending, Inc (CGBD)

Over the past six months, CGBD's stock decreased by 7.8% from $12.49 to $11.52 as of May 8, 2026. Key events include the Q4 2025 earnings release with $0.33 per common share of Net Investment Income, a quarterly dividend declaration of $0.40 per share, the redemption of $85.0 million of senior unsecured notes, record origination volume in Q4 2025, the appointment of Alex Chi as CEO, and the scheduling of the Q1 2026 earnings call.

The demand for CGBD's financing solutions is closely tied to the overall economic environment and market activity for credit rather than strict calendar seasonality. The company reported a record year of originations in 2025, with significant investment fundings in the fourth quarter, indicating that market conditions and the company's origination capabilities are key drivers of demand.

Carlyle Secured Lending, Inc. (CGBD) is an externally managed specialty finance company operating as a Business Development Company (BDC). It focuses on providing flexible financing solutions, mainly senior secured lending, to middle-market companies in the United States, aiming for current income and capital appreciation through debt investments in companies backed by private equity sponsors.

Carlyle Secured Lending, Inc. primarily focuses its investment activities on middle-market companies located within the United States.

CGBD benefits from its affiliation with The Carlyle Group Inc. Fitch Ratings affirmed CGBD's Long-Term Issuer Default Rating (IDR) at 'BBB-' with a Stable Outlook, reflecting access to resources, senior investment focus, and experienced management. Morningstar DBRS confirmed Carlyle Secured Lending, Inc.'s Long-Term Credit Ratings at BBB (high) with Stable Trends, highlighting solid earnings but noting lower earnings in Q1 2025 due to reduced net investment income.

CGBD has a diverse ownership structure, with 159 institutional owners holding 37.42% of the company, insiders holding 2.25%, and retail investors accounting for 60.33%. Major institutional owners include Creative Planning, Morgan Stanley, and Rivernorth Capital Management, Llc. The largest individual shareholder is Sjukfoersaekringsaktiebolag Afa, owning 1.06% of the company.